Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Logan

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countriesJulia del Amo, Santiago Moreno, Heiner C Bucher, et al.
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
AIDS (London, England)|May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyLauren E Cain, Andrew Phillips, Sara Lodi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries, Lauren E Cain, Andrew Phillips, et al.
AIDS (London, England)|September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, Maile Ray, Roger Logan, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Medicine|October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individualsLauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countriesJulia del Amo, Santiago Moreno, Heiner C Bucher, et al.
The Lancet. HIV|October 2, 2015
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studySara Lodi, Andrew Phillips, Roger Logan, et al.
AIDS (London, England)|May 2, 2012
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational studyLauren E Cain, Andrew Phillips, Sara Lodi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2015
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries, Lauren E Cain, Andrew Phillips, et al.
AIDS (London, England)|September 23, 2009
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals, Maile Ray, Roger Logan, et al.
American Journal of Epidemiology|May 8, 2019
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With ApplesSara Lodi, Andrew Phillips, Jens Lundgren, et al.
Medicine|October 15, 2016
Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individualsLauren E Cain, Ellen C Caniglia, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2017
Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or OlderSara Lodi, Dominique Costagliola, Caroline Sabin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 20, 2016
When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational StudyEllen C Caniglia, Caroline Sabin, James M Robins, et al.
Pageof 4